Table 2. Univariate Cox regression analysis of clinicopathological characteristics influencing the overall survival of pancreatic cancer patients.
| Variables | Univariate |
||
|---|---|---|---|
| HR | 95% CI | P-value | |
| Gender | 0.265 | ||
| Male vs female | 1.337 | 0.803–2.226 | |
| Age (years) | 0.366 | ||
| >60 vs ≤60 | 1.257 | 0.765–2.064 | |
| Tumor site | 0.490 | ||
| Body vs head | 1.195 | 0.721–1.980 | |
| Tumor size (cm) | 0.715 | ||
| ≤3 vs >3 | 1.103 | 0.650–1.872 | |
| G: tumor grading | 0.196 | ||
| III–IV vs I–II | 1.766 | 0.747–4.175 | |
| pT stage | 0.802 | ||
| pT1-pT2 vs pT3-pT4 | 1.081 | 0.587–1.990 | |
| pN stage | 0.004 | ||
| Present vs absent | 2.248 | 1.300–3.887 | |
| pM stage | 0.357 | ||
| Present vs absent | 2.513 | 0.353–17.88 | |
| pTNM stage | 0.002 | ||
| II–IV vs I | 2.170 | 1.319–3.571 | |
| GFAT1 expression | <0.001 | ||
| High vs low | 3.126 | 1.856–5.263 | |
Abbreviations: CI, confidence interval; HR, hazard ratio; P < 0.05 was considered statistically significant.